BREAKING

Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 41 minutes ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 3 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 5 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 6 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 6 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 7 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 9 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 9 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 10 hours ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 10 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 41 minutes ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 3 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 5 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 6 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 6 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 7 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 9 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 9 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 10 hours ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 10 hours ago

ADVERTISEMENT

AlphaGraphs

PFE Earnings: All you need to know about Pfizer’s Q1 2023 earnings results

Pfizer Inc. (NYSE: PFE) reported first quarter 2023 earnings results today. Revenues declined 29% year-over-year to $18.3 billion. Reported net income fell 30% to $5.5 billion, or $0.97 per share, compared to last year. Adjusted EPS was down 24% to $1.23. Both revenue and earnings beat estimates. For the full year of 2023, Pfizer expects […]

May 2, 2023 1 min read

Pfizer Inc. (NYSE: PFE) reported first quarter 2023 earnings results today.

Revenues declined 29% year-over-year to $18.3 billion.

Reported net income fell 30% to $5.5 billion, or $0.97 per share, compared to last year. Adjusted EPS was down 24% to $1.23.

Both revenue and earnings beat estimates.

For the full year of 2023, Pfizer expects revenue of $67-71 billion.

ADVERTISEMENT

Prior performance

Pfizer-Q4-2022-Earnings-Infographic

ADVERTISEMENT